Schneck, Noam http://orcid.org/0000-0003-4522-4895
Tu, Tao
Falcone, Harry Rubin
Miller, Jeffrey M.
Zanderigo, Francesca
Sublette, M. Elizabeth
Oquendo, Maria A. http://orcid.org/0000-0003-3139-4420
Stanley, Barbara
Burke, Ainsley
Ochsner, Kevin
Sajda, Paul http://orcid.org/0000-0002-9738-1342
John Mann, J. http://orcid.org/0000-0002-0265-6586
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (5P50MH090964, 5P50MH090964, 5P50MH090964, 5P50MH090964)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
Article History
Received: 14 August 2019
Revised: 7 April 2020
Accepted: 14 April 2020
First Online: 30 April 2020
Compliance with ethical standards
:
: JJM receives royalties for commercial use of the C-SSRS from the Research Foundation for Mental Hygiene and has stock options in Qualitas Health, a start- up developing a PUFA supplement. PS is the majority owner and Chairman of the Board of Neuromatters LLC, a brain computer interface neuromarketing and gaming company. MAO receives royalties for the commercial use of the Columbia-Suicide Severity Rating Scale. Her family owns stock in Bristol Myers Squibb. The remaining authors have no conflicts of interests to declare.